Omnicom Health Group’s Post

Behind this simple yet incredible statistic comes complexity. For each of these patients, their diagnosis comes with a set of medical, emotional, and logistical challenges requiring specialised attention, knowledge, and support. If you know someone who has an advanced and rare cancer in Australia, please get in contact with us on our site or via our contact details above. 📊💪 #RareCancerAwareness #TogetherForChange"" #RareCancerWarrior #StrengthInRareness"" #cquence #cquenceaustralia

We've launched a new partnership with Osara Health to give our customers on claim for cancer access to the Cancer Coach service. The program provides 1:1 support from a health coach, symptom tracking and important healthcare resources to support customers on what may be a long and challenging cancer journey. Read more on the partnership here > https://lnkd.in/gxzkYpmt #lifeinsurance #clearview #wellness

Energetic start of the year by reflecting on 2023 achievements so that everyone has perspective on what should be the focus to achieve maximum impact in 2024. I am so proud of being a partner of MAKNA - Majlis Kanser Nasional in their journey towards providing support to cancer patients. I have seen first hand their commitment, determination and professionalism. The #ThirdSector organizations not only add true value to society but are an integral part of the national economy. #ReadyForTomorrowToday #ThreadAdvisory

In this webinar, Eric Brown, MD, FACS; Erica Giblin, MD; and James V. Pellicane, MD, discuss how #PreludeDx’s #DCISionRT and its newly integrated Residual Risk Subtype (RRt) has played a significant role in treatment decision making for their ductal carcinoma in situ (#DCIS) patients. These key opinion leaders discuss the differentiating factors of actual patient cases, and the impact of RRt and patient preference on the shared decision for treatment. For a recap of the webinar click https://lnkd.in/gnjUZDgE To get started with DCISionRT and participate in the #Commit20Challenge contact PreludeDx. #bcsm @compbreastcare @HamrickLeona #breastcancer

🔬✨ New cancer screening tests are bringing hope for better outcomes and lower healthcare costs! But, Natalie Kelly, our Head of Underwriting, Claims & R&D, advises us to proceed with caution. 🚦 As someone who gets anxious just thinking about doctor visits, I appreciate the promise of MCED tests—simple blood tests for early cancer detection. 🩸 Yet, they're still in the early stages. 🧪 Natalie emphasizes that while these tests could be revolutionary in catching cancers early and reducing treatment costs, we need to carefully evaluate their potential, risks, and implications for insurers. This cautious approach is essential to ensure that these tests are reliable and effective before they become a standard practice. Let's be optimistic but prudent! 🌟💉 Read her blog to learn more: https://ow.ly/nw3x30sEs22 #CancerScreening #HealthcareInnovation #EarlyDetection #MedicalResearch #InsuranceIndustry #NatalieKelly #MCEDTests #FutureOfMedicine #HealthTech #SwissRe

Knowing prior to surgery whether you have a patient that falls into the DCISionRT Residual Risk category can help with surgical planning and type of radiation modality decisions. Knowing and understanding the biology helps with those under-treatment and over-treatment dilemmas.

📺 Catch Daniel Joyce's, MD, discussion with Sarah Psutka, MD, MSc, at #AUA24 on updates in #KidneyCancer research and how the treatment paradigm is changing as a result of #KEYNOTE564. 🎥 Watch Now:

AI-powered cancer screening is revolutionizing early detection, but most of these services aren't covered by insurance yet. Important points to consider: 🤖 AI technology is making significant strides in improving cancer screening accuracy and early detection. Despite its potential, many AI cancer screening methods are not yet covered by insurance, posing financial challenges for patients. 🏥 The healthcare industry is at a crossroads, balancing innovation with accessibility and affordability. Staying informed about these developments can help you advocate for better healthcare solutions. #AICancerScreening #HealthcareInnovation #MedicalTechnology #InsuranceCoverage #PatientCare #HealthTrends

An interesting development in navigation reimbursement. Some highlights on how to pursue billing for navigation services.

➡️ What can be achieved by bringing together 🤝 healthcare professionals, cancer patients and members of patient support organisations to think about #telemedicine? No less than 10 user goals 🎯 (among other outcomes 😉 ), presented at eCAN's Task 8.2 The Task 8.2 document is available on our website 🌐 , but if you are in a hurry today, we make it easy for you and summarise its most important results here 👇 🗞️ https://lnkd.in/dbyqGdcE #HealthUnion #EU4Health